Erectile Dysfunction in the Cardiac Patient

Comprehensive Therapy

Volumn 30, Issue 1, 2004, Pages 50-54

  Kloner, Robert A ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b GOOD SAMARITAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; DOXAZOSIN; GLYCERYL TRINITRATE; ISOSORBIDE DINITRATE; ISOSORBIDE MONONITRATE; NITRIC OXIDE DONOR; PHOSPHODIESTERASE V INHIBITOR; SILDENAFIL; TADALAFIL; VARDENAFIL;

ADULT; DIABETES MELLITUS; DRUG EFFICACY; DRUG SAFETY; DYSLIPIDEMIA; ERECTILE DYSFUNCTION; HEART DISEASE; HUMAN; HYPERTENSION; MALE; OBESITY; PHYSICAL ACTIVITY; REVIEW; RISK FACTOR; SMOKING;

EID: 2342460339     PISSN: 00988243     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12019-004-0024-0     Document Type: Review

References (31)

1. NIH Consensus Development Panel on Impotence. Impotence: NIH Consensus Conference JAMA. 1993;270:83-90.
2. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol. 1994;151:54-61.
3. Virag R, Bouilly P, Frydman D. Is impotence an arterial disorder? A study of arterial risk factors in 440 impotent men. Lancet. 1985;332:181-4
4. Feldman HA, Johannes CB, Derby CA, et al. Erectile dysfunction and coronary risk factors: Prospective results from the Massachusetts Male Aging Study. Prevent Med. 2000;30: 328-38.
5. Levine LA. Erectile dysfunction causes, diagnosis and treatment. Compr Ther. 1989;15:54-8.
6. Burchardt M, Burchardt T, Baer L, et al. Hypertension is associated with severe erectile dysfunction. J Urol. 2000; 164:1188-91.
7. Treasure CB, Klein JL, Weintraub WS, et al. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med. 1995;322:481-7.
8. Creager MA, Cooke JP, Mendelsohn ME, et al. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J CIin Invest. 1990;86:228-34.
9. Meredith IT, Currie KE, Anderson TJ, et al. Postischemic vasodilation in human forearm is dependent on endothelium-derived nitric oxide. Am J Physiol. 1996;270:H1435-H40.
10. Jarow J, Holmes A, Kloner RA. Viagra. New York, NY: M. Evans and Company; 1998; 1-150.
11. Kloner RA, Mullin SH, Shook T, et al. Erectile dysfunction in the cardiac patient: How common and should we treat? J Urol. 2003;170:S46-S50.
12. Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Peña BN. Development and evaluation of an abridged 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res. 1999;11:319-26.
13. Kloner RA, Jarow JP. Erectile dysfunction and sildenafil citrate and cardiologists. Am J Card. 1999;83:576-82.
14. DeBusk R, Drory Y, Goldstein I, et al. Management of sexual dysfunction in patients with cardiovascular disease: Recommendations of the Princeton Consensus Panel. Am J Cardiol. 2000;86:175-81.
15. Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA. Oral sildenafil in the treatment of erectile dysfunction. N Engl J Med. 1998;338:1397-1404.
16. Conti CR, Pepine CJ, Sweeney M. Efficacy and safety of sildenafil citrate in the treatment of erectile dysfunction in patients with ischemic heart disease. Am J Cardiol. 1999; 83(Suppl):29C-34C.
17. Kloner RA, Brown M, Prisant LM et al. Effect of sildenalfil in patients with erectile dysfunction taking antihypertensive therapy. Sildenafil Study Group. Am J Hypertension. 2001;14: 70-3.
18. Costabile RA. Optimizing treatment for diabetes mellitus induced erectile dysfunction. J Urol. 2003;170:S35-S9.
19. Kloner RA. Cardiovascular risk and sildenafil. Am J Cardiol. 2000;86:(Suppl):57F-61F.
20. Cheitlin MD, Hutter AM, Brindis RG, et al. ACC/AHA Expert Consensus Document. Use of sildenafil (Viagra) in patients with cardiovascular disease. J Am Coll Cardiol. 1999;33:273-82.
21. Zusman RM, Morales A, Glasser DB, Osterloh IH. Overall cardiovascular profile of sildenafil citrate. Am J Cardiol. 1999;83:35C-44C.
22. Webb DJ, Freestone S, Allen MJ, Muirhead GJ. Sildenafil citrate and blood pressure-lowering drugs: results of drug interaction studies with an organic nitrate and a calcium antagonist. Am J Cardiol. 1999;83:21C-8C.
23. Padma-Nathan H, Eardley I, Kloner RA, Laties AM, Montorsi F. A 4-year update on the safety of sildenafil citrate (Viagra). Urology. 2002;60:(Suppl 2B):67-90.
24. Shakir SA, Wilton LV, Boshier A, Layton D, Heeley E. Cardiovascular events in users of sildenafil: Results from first phase of prescription event monitoring in England. BMJ. 2001;322:651-2.
25. Emmick JT, Stuewe SR, Mitchell M. Overview of the cardiovascular effects of tadalafil. Europ Heart J. 2002;4(Suppl H);H32-H47.
26. Thadani U, Smith W, Nash S, et al. The effect of vardenafil, a potent and highly selective phosphodiesterase-5-inhibitor for the treatment of erectile dysfunction, on the cardiovascular response to exercise in patients with coronary artery disease. J Am Coll Cardiol. 2002;40:2006-12.
27. Arruda-Olson AM, Mahoney DW, Nehra A, Leckel M, Pellikka PA. Cardiovascular effects of sildenafil during exercise in men with known or probable coronary artery disease. A randomized crossover trial. JAMA. 2002;287:719-25.
28. Fox, KM, Thadani U, Ma PT, Nash SD. Time to onset of limiting angina during treadmill exercise in men with erectile dysfunction and stable chronic angina: Effect of sildenafil citrate [Abstract]. Circulation. 2001;107:II0601.
29. Patterson D, MacDonald TM, Effron MB, et al. Tadalafil does not affect time to ischemia during exercise stress testing in patients with coronary artery disease. Circulation. 2002;106:(Suppl II):II-330.
30. Hermann HC, Chang G, Klugherz BD et al. Hemodynamic effects of sildenafil in men with severe coronary artery disease. N Engl J Med. 2000;342:1622-6.
31. McCullough AR, Barada JH, Fawzy A, Guay AT, Hatzichristou D. Achieving treatment optimization with sildenafil citrate (Viagra®) in patients with erectile dysfunction. Urology. 2002;60:(Suppl 2B):28-38.